In Brief
This article was originally published in The Rose Sheet
You may also be interested in...
Senate Committee Restores FDA Funding For FY ’12
The Senate Appropriations Committee gives FDA a boost for fiscal 2012 that likely will stick, thanks to the recent debt ceiling compromise.
Novel Brain Penetrant For Treating X-ALD Among Raft Of New EU Filings
Investigational products from Minoryx and a host of other companies targeting a range of diseases are now under review by the European Medicines Agency for potential EU approval.
Joint Mission: FDA And VA Partner On Device Development Initiative
The US Food and Drug Administration and the Veterans Health Administration are partnering to create tools that can help novel technology reach patients more quickly and easily.